Skip to main content

Valuing Contingent Value Rights in M&A Transactions

In many acquisitions, the buyer and seller disagree on what the company is worth. The seller believes future growth and earnings will be strong. The buyer is more cautious. Rather than walk away from a deal, they structure a solution: the buyer pays a base price today, plus an additional contingent payment if specified financial targets are met. This contingent payment mechanism is called a Contingent Value Right (CVR).

CVRs bridge valuation gaps by making part of the purchase price depend on future performance. If the company hits revenue or profit targets after the acquisition closes, shareholders receive additional payment. If targets are missed, the contingent payment shrinks or disappears. This transfers some of the buyer's execution risk to the seller—an incentive for sellers to overstate projections, but also a reality check: sellers who believe in their projections should be willing to accept CVRs rather than insist on higher upfront payments.

Valuing a CVR requires estimating the probability that performance targets will be achieved, the timing of payments, and the appropriate discount rate. It's partially a valuation problem (how much is the contingent payment worth?) and partially a legal problem (how are disputes about achievement resolved?).

Quick definition: A Contingent Value Right (CVR) is a contractual right entitling shareholders to receive additional consideration if the acquired company achieves specified financial milestones (revenue, EBITDA, earnings, or other metrics) during a defined measurement period post-close, typically 12–36 months.

Key Takeaways​

  • CVRs are used in acquisitions to bridge valuation gaps by making part of the purchase price contingent on achieving post-close performance targets
  • The value of a CVR equals the maximum payment multiplied by the probability of achieving targets, discounted to present value at an appropriate risk-adjusted rate
  • Probability assessment depends on the credibility of projections, the company's historical performance, the baseline target difficulty (how close targets are to pre-close performance), and factors outside management's control
  • CVRs can create misalignment between buyer and seller when the buyer controls execution but the seller retains financial exposure; governance and clear metrics are essential
  • Common targets include revenue, EBITDA, gross margin, customer acquisition, or regulatory approvals; revenue targets are most common but hardest to hit post-acquisition
  • Accounting treatment of CVRs (as equity or liability) and tax treatment (deductible vs. non-deductible) affect the net cost to the buyer and the after-tax value received by selling shareholders

Understanding the Role of CVRs in M&A​

Acquisition pricing requires estimating a company's future cash flows, then agreeing on a discount rate that reflects buyer and seller perspectives on risk. When buyer and seller have materially different views, deal negotiations stall. CVRs solve this problem by splitting the payment: a base price reflecting conservative projections, plus contingent payments linked to actual performance.

CVRs are particularly common in:

  • Acquisitions of high-growth private companies where the seller has strong confidence in future growth but the buyer is more skeptical
  • Pharmaceutical and biotech acquisitions where FDA approval or clinical trial results determine value
  • Technology acquisitions where customer retention or subscription renewal rates are uncertain
  • Earn-out heavy deals where the seller wants to finance part of the acquisition by remaining exposed to upside

The CVR structure provides benefits to both parties. Sellers keep some upside if they're right about growth. Buyers reduce the risk of overpaying by making payment conditional on achieving projections. But CVRs also create potential conflicts: the buyer, now the owner, controls how the business is run, yet the seller is financially exposed if performance lags.

This governance tension is why well-drafted CVR agreements specify clear metrics, measurement methodologies, and dispute resolution processes. Vague language like "subject to continued growth" creates litigation risk.

Valuation Framework: Probability-Weighted Contingent Payment​

The fundamental formula for valuing a CVR is straightforward:

CVR Value = (Maximum Contingent Payment) × (Probability of Achievement) / (1 + Discount Rate)^Years

Step 1: Define the maximum contingent payment. This is specified in the acquisition agreement. Common structures include:

  • Up to $X million if EBITDA in year 1 post-close exceeds $Y million
  • Up to X% of deal consideration if revenue grows at Y% annually for 3 years
  • Tiered payments: $5M if EBITDA is $20–25M, $15M if EBITDA is $25–30M, $25M if EBITDA exceeds $30M

Step 2: Assess the probability of achieving targets. This is the valuation art. It requires analyzing:

  • Pre-acquisition historical performance and growth trends
  • The credibility of seller projections (do they align with history?)
  • The difficulty of the target (is it conservative relative to recent performance, or aggressive?)
  • Post-close factors: buyer's operational capabilities, market conditions, customer retention

If a company has grown revenue at 10% annually for three years and the acquisition agreement sets a Year 1 post-close target of 5% growth, that's a conservative target with high probability of achievement (80–95%). If the target is 25% growth, probability might be 30–50%.

Step 3: Determine the discount rate. CVR valuation typically uses a discount rate 2–4% higher than the buyer's WACC, reflecting additional risk that targets might be missed due to post-close integration issues, market changes, or measurement disputes. A buyer's typical cost of capital might be 8%, but the CVR discount rate might be 10–12%.

Step 4: Discount to present value. Contingent payments are typically made 12–36 months post-close. For a $20M contingent payment with a 60% probability of achievement, discounted at 12% over 2 years:

CVR Value = $20M × 0.60 / (1.12)^2 = $12M / 1.2544 = $9.6M

The CVR adds $9.6M to the upfront purchase price for valuation purposes. The total deal value is base price plus estimated CVR value.

Probability Assessment: The Critical Variable​

Estimating probability is where CVR valuation requires judgment and financial acumen. Several approaches exist:

Scenario-based analysis: Build three cases—Base (most likely), Upside, and Downside—and estimate the probability of each. Calculate separate CVR values for each scenario, then weight them.

For a software acquisition with a $15M contingent payment tied to retaining 90% of existing customers over year 1:

  • Base case (70% probability): 75% customer retention → $0 payment
  • Upside case (15% probability): 92% retention → $15M payment
  • Downside case (15% probability): 60% retention → $0 payment

Expected payment = (0.70 × $0) + (0.15 × $15M) + (0.15 × $0) = $2.25M

Discounted at 12% over 1 year: $2.25M / 1.12 = $2.01M CVR value.

Historical performance plus adjustment: If the company has demonstrated consistent performance, use historical growth as the baseline, then adjust for post-acquisition factors. If a company grew revenue at 12% annually for three years and the contingent target is 10% growth post-close, the probability might be 75% (you lose 3 percentage points of probability for each 1 percentage point above historical growth).

Management interviews and stress-testing: The buyer's management knows post-acquisition execution. Interview the integration team: "Given our operational model and customer base, what's the realistic probability of hitting this 8% EBITDA margin target by year 1?" That informed estimate beats mechanical projections.

Comparison to market data: If comparable acquisitions with similar targets had achievement rates, benchmark against those. Pharmaceuticals and biotech publish CVR achievement rates. Technology companies buying software companies have data on customer retention post-acquisition. These benchmarks provide reality checks.

The danger in probability assessment is overconfidence. Sellers, eager to justify their projections, tend to assign too-high probabilities. Buyers, skeptical of targets, assign too-low probabilities. The truth is usually between. A disciplined approach uses multiple methods and documents assumptions.

CVR Structures: Tiered, Basket, and Clawback Provisions​

CVR agreements are rarely simple single-target arrangements. They typically include protective provisions:

Tiered payments: Instead of an all-or-nothing structure, payments increase with achievement. An acquisition of a software company might structure it as:

  • $5M if revenue growth is 8–12%
  • $10M if revenue growth is 12–16%
  • $20M if revenue growth exceeds 16%

This reduces all-or-nothing risk and better aligns incentives.

Basket provisions: A minimum threshold below which no payment is made, and a maximum ceiling above which payments cap out. If the maximum CVR payment is $20M and the basket is set at 95% of target, payments only occur if the company exceeds 95% of target revenue. Below 95%, the CVR pays zero. This protects the buyer from small misses.

Clawback provisions: If the acquiring company makes aggressive cost cuts that reduce earnings, but those cuts achieve the EBITDA target, does the contingent payment apply? Clawback provisions prevent the buyer from achieving targets by unsustainable means. For instance, if the target is $30M EBITDA and the buyer achieves it by cutting R&D to dangerous levels, a clawback might reduce the contingent payment.

Earnout caps and floors: Some CVR agreements include flooring (if you miss the target by small amounts, you still get a payment proportional to achievement) and caps (payments never exceed X% of the deal consideration, even if targets are dramatically exceeded). These protect both parties from extreme outcomes.

Adjustment mechanisms: Agreements typically allow for adjustments to targets based on external factors (interest rate changes, acquisition synergies, customer losses due to buyer actions). A seller shouldn't lose contingent payment because the buyer made poor strategic decisions. Well-drafted CVR agreements specify adjustment procedures to prevent disputes.

Flowchart​

Real-World Example: Technology Acquisition with Customer Retention CVR​

TechCorp acquired SaaS startup CloudMetrics for a base price of $50 million. CloudMetrics provided customer analytics software with an annual revenue of $8 million. The acquisition agreement included:

CVR Structure:

  • Contingent payment of up to $15 million based on customer retention
  • Measurement period: 12 months post-close
  • Target: 95% of pre-acquisition customers still active at Month 12
  • Tiered: 90–95% retention = $5M, 95–98% retention = $10M, above 98% = $15M

Probability Assessment:

  • Pre-acquisition retention: 92% annual (strong for the industry)
  • Historical churn: 8% per year, primarily to competitors or customer bankruptcy
  • TechCorp's platform: A stronger product, reducing churn to estimated 5% if well-integrated
  • Integration plan: Aggressive within first 6 months to lock in existing customers
  • Market risk: Moderate downturn risk (30% chance of mild recession)

Scenario analysis:

  • Base case (60% probability): 94% retention → $5M payment
  • Upside case (20% probability): 97% retention → $10M payment
  • Downside case (20% probability): 89% retention → $0 payment (below 90% basket)

Expected contingent payment = (0.60 × $5M) + (0.20 × $10M) + (0.20 × $0) = $5M

Discounted at 13% over 1 year: $5M / 1.13 = $4.42M

Accounting treatment: TechCorp recorded the CVR as a liability on its balance sheet at $4.42M. This affects book value and earnings immediately. If actual year 1 retention is 94% and the $5M payment is made, the $0.58M difference (estimated $4.42M vs. actual $5M) flows through earnings as an adjustment to goodwill.

Accounting and Tax Considerations​

Accounting Treatment (ASC 805): Contingent consideration is measured at fair value and recorded as part of the acquisition price. The acquirer updates the CVR valuation each reporting period based on new information about achievement probability. If achievement probability increases, the CVR liability on the balance sheet increases, flowing through the income statement. This can create earnings volatility.

For example, if at Month 6 post-close, retention is tracking at 96%, the buyer might increase the CVR probability assessment from 60% to 75%, causing a $1.16M increase in the liability and a charge to earnings.

Tax Treatment: For sellers, contingent consideration is treated as additional purchase price for tax purposes. It's not immediately taxable; rather, it's added to the basis used to calculate gain on sale. When the contingent payment is made (or not made), that affects the total proceeds and thus the capital gain calculation.

For buyers, contingent payments are typically capitalized as part of the acquisition price and added to goodwill, making them non-deductible. However, if the CVR is structured as compensation to key employees for staying post-close (rather than purchase price), it might be deductible. Tax structuring of CVRs requires careful legal review.

Common Mistakes in CVR Valuation​

Anchoring on the maximum payment without rigorous probability assessment. Teams often use the CVR maximum as if it's the expected value. A $20M contingent payment is valued at $20M without discounting for probability or time value. This overstates deal value and leads to post-acquisition earnings disappointment.

Setting achievement targets that are too aggressive. If the acquisition target is 25% growth and the company has historically grown 10%, targets are unrealistic. Buyers then face a choice: invest heavily to force achievement, or accept that the seller's projections were optimistic and the CVR will go unpaid. Setting achievable targets makes CVRs meaningful.

Ignoring post-acquisition integration challenges. Acquisitions are disruptive. Customer turnover often increases immediately post-close due to change aversion, integration issues, and key personnel departures. CVR targets that don't account for this integration dip are too optimistic. Conservative targets that account for a 12–18 month stabilization period are more realistic.

Creating perverse incentives between buyer and seller. If the CVR target is EBITDA and the buyer can achieve it by cutting R&D investment, the seller loses upside from long-term growth but the buyer saves costs. Well-drafted CVR agreements prevent this with adjustment mechanisms and clawback provisions, but sloppy agreements create disputes.

Failing to account for measurement disputes. What if the buyer and seller disagree on whether the target was met? If the agreement doesn't specify how EBITDA is calculated post-acquisition, disputes arise. Does EBITDA include acquisition-related costs? Does it reflect only the acquired company's results, or combined results? Clear definitions prevent litigation.

Frequently Asked Questions​

Q: How long is the typical CVR measurement period? A: Most commonly 12–24 months post-close. Longer periods (3 years) are used for targets that take time to materialize, like market share gains or FDA approvals. Shorter periods (6–12 months) are used for retention-based metrics that can be measured quickly.

Q: Can CVRs be traded or transferred? A: Generally yes, unless the acquisition agreement specifically restricts transfer. If targets are linked to shareholder actions (retaining customers, staying employed), transfers might be restricted to prevent speculators from influencing target achievement.

Q: What happens if the buyer sells the acquired company before the CVR is paid? A: This is a common issue. Agreements typically specify that CVR obligations either vest on sale (the buyer must pay out estimated CVR value to the seller), or the buyer's successor assumes the obligations. Some agreements allow the buyer to resolve the CVR with sellers immediately if the company is sold, using the acquisition price to estimate CVR achievement probability.

Q: Is there a difference between CVRs and earnouts? A: CVRs and earnouts are nearly identical. The term "earnout" is more common in private company acquisitions where seller financing is involved. "CVR" is more common in public company acquisitions structured as contingent payments post-close. Functionally, they're the same: contingent payment based on post-close performance.

Q: How are CVRs recorded in financial statements? A: As a liability (using ASC 805, Combinations) at fair value. Each reporting period, the liability is remeasured based on updated estimates of achievement probability. Changes flow through earnings. Once the contingent period ends and actual results are known, the liability is settled and any differences are adjusted against goodwill.

Q: Can CVRs be structured as equity instead of debt? A: Yes, though it's less common. If a CVR is structured as an earned-in equity stake (sellers receive additional shares if targets are met), it's recorded as equity rather than a liability. This avoids balance sheet volatility. However, equity-based CVRs are typically used only in deals where sellers retain some ownership stake post-close.

Summary​

Contingent Value Rights bridge valuation gaps in acquisitions by making part of the purchase price contingent on achieving post-close performance targets. The value of a CVR is determined by the probability of achieving targets, the magnitude of the contingent payment, and the appropriate discount rate. Rigorous probability assessment—combining historical performance, target difficulty, post-acquisition integration challenges, and market conditions—is essential to valuation credibility.

Well-drafted CVR agreements specify clear metrics, adjustment mechanisms, and dispute resolution processes. Common structures include tiered payments (increasing with achievement), baskets (minimum thresholds), and clawbacks (preventing buyers from artificially achieving targets). CVRs create win-win solutions in negotiations when buyer and seller have different growth expectations, but they require discipline in valuation and governance to prevent disputes and misalignment.

For sellers, CVRs allow participation in upside if projections prove correct. For buyers, CVRs reduce the risk of overpaying by making payment conditional on actual performance. Both parties benefit when targets are realistic and incentives are aligned.

Next: Earnout Adjustments​

The next article explores earnouts in depth, where seller financing and deferred consideration create additional valuation challenges beyond simple CVRs.

Read: Earnout Provisions